appScorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
HighStrong financials and growth story over the years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
News & Opinions
Indraprastha Medical Corp hits 52-week high after HDFC Bank sells 27.8 lakh shares
6 months ago•Moneycontrol
Khaitan (India) Ltd leads gainers in ‘B’ group
1 year ago•Business Standard
Indraprastha Medical Corporation standalone net profit rises 108.03% in the September 2022 quarter
1 year ago•Business Standard
Board of debt-free multibagger stock fixes record date for dividend
2 years ago•Livemint
Indraprastha Medical Corporation reports standalone net profit of Rs 15.44 crore in the June 2021 quarter
3 years ago•Business Standard
Indraprastha Medical Corporation Q4 profit rises 132.5% to Rs15.10cr
3 years ago•India Infoline
Indraprastha Medical Q4 PAT grows 132% to Rs 15 cr
3 years ago•Business Standard